Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1985 Jul;40(7):508–514. doi: 10.1136/thx.40.7.508

Asbestosis: assessment by bronchoalveolar lavage and measurement of pulmonary epithelial permeability.

A R Gellert, J A Langford, R J Winter, S Uthayakumar, G Sinha, R M Rudd
PMCID: PMC460122  PMID: 4035617

Abstract

Thirty two patients with asbestosis were assessed by means of bronchoalveolar lavage (27 patients) and the half time clearance from lungs to blood (T1/2LB) of an inhaled aerosol of diethylenetriamine pentacetate (DTPA) labelled with technetium 99m (32 patients). T1/2LB was also measured in 20 non-smoking normal individuals and 17 smokers without a history of exposure to asbestos. Thirteen patients (46%) showed an increase in the percentage of neutrophils with or without an increase in the percentage of eosinophils and eight (29%) showed an increased percentage of lymphocytes. The number of neutrophils plus eosinophils expressed as a percentage of the total count was positively correlated with the length of the history of disease (r = 0.53, p less than 0.025) and greater percentages were associated with more severe impairment of lung function. Smokers had lower percentages of lymphocytes than non-smokers (p less than 0.002) and showed increased proportions of neutrophils and eosinophils more often than non-smokers (p less than 0.05). In 18 non-smokers with asbestosis the mean T1/2LB was 33.8 (range 10.0-62.0) minutes, significantly less than 57.2 (30.5-109) minutes in 20 non-smoking normal subjects (p less than 0.002). In non-smokers shorter T1/2LB correlated with a longer time since first exposure to asbestos (r = -0.65, p less than 0.005), longer duration of exposure (r = -0.70, p less than 0.001), and a shorter time since last exposure (r = 0.59, p less than 0.01). Shorter T1/2LB was also associated with increased inflammatory activity as shown by higher bronchoalveolar lavage cell counts (r = -0.53, p less than 0.025) and higher combined percentages of neutrophils, eosinophils, and lymphocytes (r = -0.47, p less than 0.05). The techniques of bronchoalveolar lavage and measurement of inhaled solute clearance may be useful in assessing inflammatory activity in asbestosis.

Full text

PDF
508

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ashcroft T., Heppleston A. G. The optical and electron microscopic determination of pulmonary asbestos fibre concentration and its relation to the human pathological reaction. J Clin Pathol. 1973 Mar;26(3):224–234. doi: 10.1136/jcp.26.3.224. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bégin R., Cantin A., Drapeau G., Lamoureux G., Boctor M., Massé S., Rola-Pleszczynski M. Pulmonary uptake of gallium-67 in asbestos-exposed humans and sheep. Am Rev Respir Dis. 1983 May;127(5):623–630. doi: 10.1164/arrd.1983.127.5.623. [DOI] [PubMed] [Google Scholar]
  3. Crystal R. G., Gadek J. E., Ferrans V. J., Fulmer J. D., Line B. R., Hunninghake G. W. Interstitial lung disease: current concepts of pathogenesis, staging and therapy. Am J Med. 1981 Mar;70(3):542–568. doi: 10.1016/0002-9343(81)90577-5. [DOI] [PubMed] [Google Scholar]
  4. De Vuyst P., Jedwab J., Dumortier P., Vandermoten G., Vande Weyer R., Yernault J. C. Asbestos bodies in bronchoalveolar lavage. Am Rev Respir Dis. 1982 Dec;126(6):972–976. doi: 10.1164/arrd.1982.126.6.972. [DOI] [PubMed] [Google Scholar]
  5. Fondimare A., Desbordes J. Asbestos bodies and fibers in lung tissues. Environ Health Perspect. 1974 Dec;9:147–148. doi: 10.1289/ehp.749147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Haslam P. L., Turton C. W., Heard B., Lukoszek A., Collins J. V., Salsbury A. J., Turner-Warwick M. Bronchoalveolar lavage in pulmonary fibrosis: comparison of cells obtained with lung biopsy and clinical features. Thorax. 1980 Jan;35(1):9–18. doi: 10.1136/thx.35.1.9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hunninghake G. W., Gadek J. E., Kawanami O., Ferrans V. J., Crystal R. G. Inflammatory and immune processes in the human lung in health and disease: evaluation by bronchoalveolar lavage. Am J Pathol. 1979 Oct;97(1):149–206. [PMC free article] [PubMed] [Google Scholar]
  8. Jones J. G., Minty B. D., Lawler P., Hulands G., Crawley J. C., Veall N. Increased alveolar epithelial permeability in cigarette smokers. Lancet. 1980 Jan 12;1(8159):66–68. doi: 10.1016/s0140-6736(80)90493-6. [DOI] [PubMed] [Google Scholar]
  9. Jones J. G., Royston D., Minty B. D. Changes in alveolar-capillary barrier function in animals and humans. Am Rev Respir Dis. 1983 May;127(5 Pt 2):S51–S59. [PubMed] [Google Scholar]
  10. Keogh B. A., Crystal R. G. Alveolitis: the key to the interstitial lung disorders. Thorax. 1982 Jan;37(1):1–10. doi: 10.1136/thx.37.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Rudd R. M., Haslam P. L., Turner-Warwick M. Cryptogenic fibrosing alveolitis. Relationships of pulmonary physiology and bronchoalveolar lavage to response to treatment and prognosis. Am Rev Respir Dis. 1981 Jul;124(1):1–8. doi: 10.1164/arrd.1981.124.1.1. [DOI] [PubMed] [Google Scholar]
  12. Schoenberger C., Hunninghake G., Gadek J., Crystal R. Inflammation and asbestosis: characterization and maintenance of alveolitis following acute asbestos exposure. Chest. 1981 Jul;80(1 Suppl):70–71. doi: 10.1378/chest.80.1_supplement.70s. [DOI] [PubMed] [Google Scholar]
  13. Studdy P. R., Rudd R. M., Gellert A. R., Uthayakumar S., Sinha G., Geddes D. M. Bronchoalveolar lavage in the diagnosis of diffuse pulmonary shadowing. Br J Dis Chest. 1984 Jan;78(1):46–54. [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES